COLORADO SPRINGS, Colo.,
Sept. 26, 2013 /PRNewswire/ -- The
X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing primarily in cannabinoid formulation-based health and
wellness solutions, is pleased to announce that the Company's Board
of Directors has selected the name Endocan Corporation as the new,
industry-driven name of the Company. The name change began
with the Nevada Secretary of State
filings yesterday. The next steps will include FINRA for a symbol
change to match the new name. The Endocan™ name change will have no
effect on the Company's share structure, corporate organization,
business model operations, or corporate governance.
The Company has established two subsidiaries in The Netherlands, including Endocan B.V., for
the Company's expanding European operations. In the United States dispensary owners will be
licensed to use the Company's brands and formulations for retail
distribution through licensing agreements with the Endocan™ brand
name. Endocan Corporation now serves as the enhanced brand and
refined image to be used in conjunction with all of the Company's
activities, products, and services. The updated and revised
Company website and corporate collateral package, will be released
shortly.
Endocan™ was chosen by the Board as a direct reference to the
endocannabinoid system of the human body. The endocannabinoid
system is a group of neuromodulatory compounds and their receptors
that are involved in a variety of fundamental physiological
processes including pain-sensation, immune function, stress, sleep,
mood, appetite, and memory. Cannabinoids from plants,
including those found in the Cannabis genus, as well as those
autonomously produced within living biological systems, work
together in the operation of the endocannabinoid system. The
modulation of this system is the basis for cannabinoid-based
medical treatments to assist patients to improve their health and
well-being.
"The Company's branding is an essential component in our
messaging to reflect the nature of our cannabinoid based products
that we are developing to treat a variety of illnesses," stated Dr.
Dorothy Bray, President of Endocan
Corporation.
About Endocan Corporation
Endocan Corporation is currently developing new natural
cannabinoid containing products based on innovative formulations to
utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known
and applied for thousands of years. With the aid of scientific
research, Endocan Corporation is translating such knowledge into
development of effective cannabinoid formulation-based health and
wellness solutions as well as cosmeceutical, nutraceutical, and
food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal
needs and will evolve with the introduction of new formulations and
products, advancing the Company within the expanding
multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
words such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. The Company does not undertake any duty nor does it intend
to update the results of these forward-looking statements.
X-Change Corp.
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
1.866.326.5595
Investment Inquiries
Robert Kane
CFO, Sr VP of Business Development
rkane@xchangecorp.com
+1.561.420.4824
SOURCE X-Change Corporation